LC-280126 | Interleukin Related interleukin-related.com

Product Name :
LC-280126

Search keywords :
NecroX-7

drugId :
null

Target Vo:
Nuclear factor NF-kappa-B complex

Target Vo Short Name :
NF-κB

Moa_Name:
Nuclear factor NF-kappa-B complex inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Lg Life Sciences Ltd

Active Company_Name :
MitoImmune Therapeutics Inc

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:
ST Elevation Myocardial Infarction

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse CD117 Antibody Autophagy
Cytochrome C Rabbit mAb Technical Information
NR1H4 Antibody: NR1H4 Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-NR1H4 polyclonal antibody. NR1H4 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, sheep background without labeling.

Author: Interleukin Related

Related Posts